Ras-mutant cancers are sensitive to small molecule inhibition of V-type ATPases in mice

Mutations in Ras family proteins are implicated in 33% of human cancers, but direct pharmacological inhibition of Ras mutants remains challenging. As an alternative to direct inhibition, we screened for sensitivities in Ras-mutant cells and discovered 249C as a Ras-mutant selective cytotoxic agent w...

Descripción completa

Detalles Bibliográficos
Autores principales: Tolani, Bhairavi, Celli, Anna, Yao, Yanmin, Tan, Yong Zi, Fetter, Richard, Liem, Christina R., de Smith, Adam J., Vasanthakumar, Thamiya, Bisignano, Paola, Cotton, Adam D., Seiple, Ian B., Rubinstein, John L., Jost, Marco, Weissman, Jonathan S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group US 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9750872/
https://www.ncbi.nlm.nih.gov/pubmed/35879364
http://dx.doi.org/10.1038/s41587-022-01386-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9750872/
https://www.ncbi.nlm.nih.gov/pubmed/35879364
http://dx.doi.org/10.1038/s41587-022-01386-z

Ejemplares similares